Jennison Associates LLC Novo Cure LTD Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$57.2 - $74.41 $755,097 - $982,286	-13,201 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$57.05 - $95.75 $10,211 - $17,139	-179 Reduced 1.34%	13,201 $889,000
Q4 2019 Feb 07, 2020	SELL	$68.3 - $93.8 $188,098 - $258,325	-2,754 Reduced 17.07%	13,380 $1.13 Million
Q3 2019 Nov 08, 2019	BUY	$61.86 - $97.8 $6,309 - $9,975	102 Added 0.64%	16,134 $1.21 Million
Q2 2019 Aug 06, 2019	BUY	$42.22 - $63.23 $81,906 - $122,666	1,940 Added 13.77%	16,032 $0
Q1 2019 May 10, 2019	BUY	$31.96 - $56.12 $450,380 - $790,843	14,092 New	14,092 $679,000

294

75.8M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.